183 related articles for article (PubMed ID: 35313390)
1. Real-world, single-center experience of SARS-CoV-2 vaccination in immune thrombocytopenia.
Woolley P; Tailor A; Shah R; Westwood JP; Scully M
J Thromb Haemost; 2022 Jun; 20(6):1476-1484. PubMed ID: 35313390
[TBL] [Abstract][Full Text] [Related]
2. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
[TBL] [Abstract][Full Text] [Related]
4. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
Kaicker S; Martinko K; Bussel JB
Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
[TBL] [Abstract][Full Text] [Related]
5. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Sato K; Anayama M; Sumi M; Kobayashi H
Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review.
Stefani S; Buti N; Hart ACJ; Paul D; Rizvi N; Ragoonanan V; Vladescu C; Szydlo R; Ademokun C; Jansen AJG; Cooper N
Br J Haematol; 2024 Jan; 204(1):324-328. PubMed ID: 38013240
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics in immune thrombocytopenia patients after COVID-19 vaccination.
Feng Y; Quan Y; Cassady K; Zou Z; Gao Y; Zhang X
Hum Vaccin Immunother; 2022 Nov; 18(6):2119043. PubMed ID: 36069667
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
[TBL] [Abstract][Full Text] [Related]
9. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
[TBL] [Abstract][Full Text] [Related]
10. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
[TBL] [Abstract][Full Text] [Related]
11. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccination in patients with immune thrombocytopenia.
Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
Baba Y; Sakai H; Kabasawa N; Harada H
Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
Jacobs JW; Booth GS; Adkins BD
Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
[TBL] [Abstract][Full Text] [Related]
15. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
Kuter DJ
Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
[TBL] [Abstract][Full Text] [Related]
18. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
King ER; Towner E
Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
[TBL] [Abstract][Full Text] [Related]
19. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis.
Schaefers C; Paulsen FO; Frenzel C; Weisel K; Bokemeyer C; Seidel C
Br J Haematol; 2023 Apr; 201(2):222-226. PubMed ID: 36793157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]